Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01872832 · ClinicalTrials.gov registry record · Phase 1
Single and Multiple Dose Study in Japanese Subjects
A Phase 1 study, sponsored by Ardea Biosciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 46
- Enrollment target
NCT01872832 is a Phase 1 study that has completed, run by Ardea Biosciences. The registered enrollment target is 46 participants.
The verdict
NCT01872832, a Phase 1 study, has completed, sponsored by Ardea Biosciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 46 participants
- Enrollment target
Study Summary
This study will explore the safety, tolerability, and serum uric acid lowering effect of RDEA3170 in healthy Japanese males to allow comparison with the Western population.
Interventions
- DRUG RDEA3170 and Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2013-06 |
| Est. Completion | 2013-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01872832
The ClinicalTrials.gov registry entry for NCT01872832 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ardea Biosciences, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RDEA3170 and Placebo is the first listed.
NCT01872832 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01872832 about?
NCT01872832 is a clinical study titled "Single and Multiple Dose Study in Japanese Subjects". This study will explore the safety, tolerability, and serum uric acid lowering effect of RDEA3170 in healthy Japanese males to allow comparison with the Western population.
What is the current status of trial NCT01872832?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 46 participants. The study started on 2013-06. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01872832?
The interventions under investigation include: RDEA3170 and Placebo (DRUG).
Who is sponsoring clinical trial NCT01872832?
This trial is sponsored by Ardea Biosciences, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.